Skip Navigation



Rheumatology Advance Access published online on April 27, 2004
Rheumatology, doi:10.1093/rheumatology/keh197
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary data
Right arrow All Versions of this Article:
43/7/852    most recent
keh197v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jakob, M.
Right arrow Articles by Martin, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jakob, M.
Right arrow Articles by Martin, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received February 5, 2004
Accepted March 16, 2004

Concise Report

Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins

M. Jakob 1*, O. Démarteau 1, R. Suetterlin 2, M. Heberer 1, I. Martin 1

1 Departments of Surgery and of Research, University Hospital, Basel, Switzerland
2 M. E. Mueller Institute, Biozentrum, University of Basel, Basel, Switzerland

* To whom correspondence should be addressed. E-mail: mjakob{at}uhbs.ch.


  Abstract

Objective. To investigate the effects of the cyclooxygenase-2 (cox-2)-dependent prostaglandins D2 (PGD2), E2 (PGE2) and F2{alpha} (PGF2{alpha}) on the redifferentiation and cartilage matrix production of dedifferentiated articular chondrocytes.

Methods. Human articular chondrocytes from three adult donors were dedifferentiated by monolayer expansion and induced to redifferentiate by culture as 3D pellets in a defined serum-free medium containing TGF-{beta}1 and dexamethasone, without or with further supplementation with PGD2, PGE2 or PGF2{alpha}. After 2 weeks, pellets were assessed histologically, immunohistochemically, biochemically and by real-time quantitative reverse transcriptase-polymerase chain reaction.

Results. All three PGs, but predominantly PGE2, reduced the staining intensity of pellets for collagen type I, whereas PGD2 and PGF2{alpha} increased the staining intensity of pellets for collagen type II and glycosaminoglycans (GAG). The GAG/DNA content of pellets was not affected by PGE2 but was increased 1.5- and 2.1-fold by PGD2 and PGF2{alpha} respectively. PGE2 reduced the expression of collagen type I mRNA (9.0-fold), whereas PGD2 and PGF2{alpha} increased the mRNA expression of collagen type II (6.2- and 4.1-fold respectively) and aggrecan (29.8- and 10.7-fold respectively).

Conclusion. In contrast to PGE2, PGD2 and PGF2{alpha} enhanced chondrogenic differentiation and hyaline cartilage matrix deposition by expanded human articular chondrocytes, and could thus be used to improve in vitro or in vivo cartilage regeneration approaches based on these cells.

KEY WORDS: Key words: Tissue engineering, Cartilage repair, Cell differentiation, Cartilage degeneration, Joint inflammation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.